Shares of WELL Health Technologies Corp. (TSE:WELL – Get Rating) have received a consensus rating of "Buy" from the eight research firms that are presently covering the firm, MarketBeat reports. Five research analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is C$9.13.
Several research firms recently weighed in on WELL. CIBC upped their price objective on shares of WELL Health Technologies from C$6.50 to C$7.50 in a report on Monday, August 15th. TD Securities upped their price objective on shares of WELL Health Technologies from C$7.00 to C$8.00 and gave the stock a "buy" rating in a report on Friday, August 12th. Finally, Eight Capital cut their price target on shares of WELL Health Technologies from C$12.00 to C$10.00 and set a "buy" rating for the company in a report on Thursday, September 15th.
Get WELL Health Technologies alerts:WELL Health Technologies Stock Performance
WELL stock opened at C$3.32 on Tuesday. The company has a market capitalization of C$752.76 million and a P/E ratio of -15.16. The company has a 50-day simple moving average of C$3.54 and a 200 day simple moving average of C$3.90. WELL Health Technologies has a fifty-two week low of C$2.98 and a fifty-two week high of C$7.71. The company has a quick ratio of 1.04, a current ratio of 1.14 and a debt-to-equity ratio of 47.93.
About WELL Health Technologies
(Get Rating)WELL Health Technologies Corp. operates as a practitioner focused digital health company in Canada, the United States, and internationally. It offers end-to-end omni-channel patient services, including primary care; physiotherapy, occupational therapy, chiropractic, dietary, mental health counselling, and sleep related services; specialized care, including gastroenterologists; diagnostic services related to cardiology, women's health, and bone/muscle health and cancer diagnostics; and telehealth services.
Featured Articles
- Oracle's Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin' It: Investors Keep Visiting McDonald's
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.